Where drug costs meet coding rules
In a medical oncology practice, drugs bought and administered in the office can account for most of the revenue — and most of the financial risk. A single infusion claim can be worth thousands of dollars, so a missing authorization, a wrong unit count or an administration code out of sequence costs far more than in other specialties. Oncology billing is as much about managing high-cost drug claims as about coding.
The drug administration hierarchy
Each encounter has one initial administration service, chosen by the main reason for the visit, and every other administration is reported as sequential, concurrent or an additional hour.
| Service | Initial | Additional |
|---|---|---|
| Chemotherapy or complex drug infusion | 96413 (up to 1 hour) | 96415 each additional hour; 96417 sequential infusion of a new drug |
| Chemotherapy push | 96409 | 96411 each additional push of a new drug |
| Therapeutic infusion (e.g. antiemetics, supportive drugs) | 96365 | 96366 additional hour; 96367 sequential; 96368 concurrent |
| Hydration | 96360 | 96361 additional hour |
Infusion start and stop times must be documented for every drug. Hydration given only to keep a line open, or alongside chemotherapy, is not separately billable. Many monoclonal antibodies and other complex biologics are reported with the chemotherapy administration codes even when they are not cytotoxic.
Drug units, wastage and NDCs
- Units: each drug is billed with its HCPCS code and the number of billing units matching the dose, which depends on the amount each code defines.
- Wastage: for single-dose vials, Medicare requires modifier JW on any discarded amount and JZ when none was discarded; the note records both.
- NDC: Medicaid and many commercial plans require the National Drug Code and quantity on each drug line.
- Biosimilars have their own HCPCS codes, and payers often prefer — or require — a specific biosimilar.
Authorization and coverage
Most commercial and Medicare Advantage plans require prior authorization for chemotherapy regimens, supportive drugs and imaging, often tied to the specific drugs, doses and number of cycles. Off-label use is generally covered when supported by recognized compendia, so authorizations and appeals cite them. Regimen changes need new approvals before the next cycle — see prior authorization services.
Clinical trials, visits and high-value A/R
Routine costs for patients in qualifying clinical trials are billed with the trial diagnosis code and modifier Q1 (routine service) or Q0 (investigational service), while items paid by the sponsor are not billed. E/M visits on infusion days need modifier 25 and separate documentation. Because every drug claim is large, denials and underpayments are worked quickly, before the practice’s drug costs come due — see A/R management.